chronic GRAFT-VERSUS-HOST DISEASE (cGVHD)

The Congress Connection: cGvHD and Transplant Key Takeaways in 2025

Between The Lines: GVHD, Episode 1 – Understanding the Foundation of Graft vs Host Disease

Tandem Meetings Transplantation and Cellular Therapy Meetings of ASTCT® and CIBMTR®

The Congress Connection: cGvHD and Transplant Key Takeaways in 2025

Molecular Pathway

Optimizing Treatment

Understanding cGVHD

Impact on Patients

Other Treatment Options

Inflammation and Fibrosis Role

Treatment under Clinical Development

Psychological & Economical impact

Clinical outcomes of cGvHD following allogeneic HSCT: A Swedish population-based real-world registry study

European Respiratory Society (ERS)/ European Society for Blood and Marrow Transplantation (EBMT) clinical practice guidelines on treatment of pulmonary cGvHD in adults

Updated European Society of Blood and Marrow Transplantation consensus recommendations for GVHD prophylaxis and management in hematological malignancies after stem-cell transplantation

Advances in the biology of chronic GVHD